Waltham, MA 2/14/11—PerkinElmer has acquired chemagen Biopolymer-Technologie AG, a provider of automated nucleic acid isolation technologies. “The addition of chemagen’s complementary products to PerkinElmer’s portfolio will provide the company with robust platforms and solutions to meet the needs of the rapidly evolving molecular diagnostics market,” stated Daniel R. Marshak, PhD, chief scientific officer and president […]
Santa Clara, CA 2/28/11—Agilent has acquired Lab901, a provider of electrophoresis equipment and consumables, for an undisclosed amount. Lab901 develops and markets the TapeStation benchtop electrophoresis instrument and Screen Tape consumables and reagents. “With the addition of Lab901’s outstanding technology and talented team, Agilent can now address customer needs across the entire span of electrophoresis […]
Millville, NJ 2/9/11—Wheaton Industries has acquired UK-based Laboratory Sales Limited (LSL), a manufacturer and distributor of tubular glass products and lab consumables. “This strategic investment further strengthens our position as a market leader of specialty packaging and related instruments for cell-based research, chemical compound, in vitro diagnostics and specialty pharmaceutical markets,” commented Wheaton Industries President […]
Radnor, PA 2/1/11—VWR International has acquired AMRESCO, a manufacturer and supplier of biochemicals and reagents for molecular biology, life sciences, proteomics, clinical and histology areas of research and production. Financial details were not disclosed. “This acquisition expands VWR’s product portfolio in the growing and critical life science arena,” stated VWR Chairman, President and CEO John […]
Tokyo, Japan 2/1/11—The Japan Times has reported that analytical instrument company JEOL will set up a joint venture for its NMR business. The new company, JEOL Resonance, will be formed with Innovation Network, a Japanese government–backed investment fund. Innovation Network plans to invest ¥1.5 billion ($18.1 million = ¥82.76 = $1) for a 50.1% share […]
Franklin Lakes, NJ 2/7/11—Becton, Dickinson and Company (BD) has agreed to acquire Accuri Cytometers, a provider of personal flow cytometers for research applications. Financial details were unavailable. BD stated that the acquisition would allow it to expand into the affordable personal flow cytometer market, which includes users in developing regions and researchers in scientific disciplines, […]
South San Francisco, CA 2/10/11—Microfluidics company Fluidigm has completed its IPO (see IBO 12/15/10), offering 5,558,333 shares of common stock at a public price of $13.50 per share. Last month, Fluidigm announced that pricing would be $13.50–$15.50 (see IBO 1/31/11). The underwriters have been granted a right to purchase up to an additional 833,750 shares […]
Washington, DC 2/7/11; Orange County, CA 2/7/11—Danaher has definitely agreed to purchase diagnostic and life science technology firm Beckman Coulter. Danaher will acquire all of Beckman Coulter’s outstanding common stock for $83.50 per share in cash, which is a 45% premium over the closing price on December 9, 2010, when rumors of a sale were […]
Washington, DC 1/20/11; Washington, DC 1/28/11—Fluidigm has announced in a filing with the SEC that it will offer 5.17 million shares of its common stock in its IPO (see IBO 12/15/10). The IPO price will be $13.50–$15.50 per share. Based on an offering price of $14.50, the company estimates raising $68.3 million, of which $15 […]
Shenzhen, China 1/25/11—Jiangsu Skyray Instruments, a supplier of atomic spectroscopy, molecular spectroscopy and GC systems, has completed an IPO on the Shenzhen stock exchange’s ChiNext market. According to the Shenzhen stock exchange, the company issued 18.5 million shares priced at CNY 65 ($9.86 = CNY 6.57 = $1) per share, with 14.8 million shares listed […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
